FDA Approved: FLUDEOXYGLUCOSE F 18 — Original Application (Kettering Medical Center)

View source ↗

Summary

FDA approved Fludeoxyglucose F-18 (FDG F-18) under an Original Application by Kettering Medical Center for use as a PET imaging radiopharmaceutical.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cancer
• Ischemic Heart Disease

Drugs mentioned

• Fludeoxyglucose F-18 (Fludeoxyglucose F-18)

Snippet

ORIG AP for FLUDEOXYGLUCOSE F 18 (FLUDEOXYGLUCOSE F-18)